Alzheimer's disease Do you Remember?

According to the Alzheimer’s disease international (ADI), 75% of dementia cases go undiagnosed globally, with certain lower- and middle-income nations reporting rates as high as 90%.Unexpectedly many dementia sufferers said that they had only received the first information after receiving their diagnosis, with no post-diagnostic care. In higher-income countries, 37% patients said that they received no post-diagnostic care, while 45% in lower-income countries said they had not been offered assistance. Informal caregivers from lower-income nations reported that 62% of the individuals in their charge did not have access to post-diagnosis support.

Globally, much more work needs to be done to increase access to knowledge, education, and resources in order to guarantee that persons with dementia have fair access to care no matter where they may reside.

Alzheimer’s disease Symptoms

1) Patient experiences occasional moments of amnesia.

2) Those who have Alzheimer’s disease exhibit a number of persistent habits and symptoms that get worse with time.

3) These may consist of memory loss that interferes with daily duties, such as maintaining appointments and difficulty with routine tasks such as meniel chores like using a microwave.

4) Issues with problem-solving.

5) Issues with speech or writing & being confused about dates or locations.

6) Reduced judgement, poor personal hygiene, and alterations in mood.

7) Isolation from the community, family, and friends.

Potential treatment for Alzheimer’s disease

A group of researchers from Bengaluru, led by T Govindaraju, a professor at the Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR), had found a potential treatment for Alzheimer’s disease, the most common form of dementia in the world.The discovery is a tiny chemical called TGR 63, which has demonstrated the ability to interfere with the process through which neurons in Alzheimer’s disease start to malfunction.

The TGR63 molecule has been demonstrated in animal trials by Govindaraju and scientists at JNCASR and an Indian-origin scientist from the KTH Royal Institute of Technology in Sweden to not only arrest the progression of the disease but even reverse it.